- Researchers from the National Institutes of Health studied a medication with existing FDA approval to see if it would work for an alternative purpose.
- Spironolactone is prescribed to treat heart conditions. Because the medication is a mineralocorticoid receptor antagonist, the researchers were interested . . .
Kindly Register to access archived content
[ultimatemember form_id="5932"]
